Treatment of Parkinson's disease under the following conditions: • Initial treatment as monotherapy, in order to delay the introduction of levodopa • In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).
Teva Pharma UK has launched generic versions of Seroquel and Seroquel XL as Quetiapine and Quetiapine XL.Other generic versions are...
Treatment of Parkinson's Disease under the following conditions: • Initial treatment as monotherapy, in order to delay the introduction of levodopa • In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations)
Exelixis, Inc. announced the initiation of STELLAR-303, a phase III pivotal trial evaluating XL 092 in combination with atezolizumab versus regorafenib in patients with metastatic colorectal cancer (CRC) that is not microsatellite instability-high or mismatch repair-deficient, who have progressed after or are intolerant to the standard of care therapy.
The FDA has approved Astagraf XL (tacrolimus extended-release capsules), from Astellas, for the prophylaxis of organ Transplant Rejection in patients...
Alzheimer's medication Reminyl XL/Razadyne (galantamine hydrobromide) from Janssen Pharma, appears to slash inflammation and insulin resistance in patients with metabolic...
Top line results were reported by Exelixis for XL 184 (cabozantinib) for the primary endpoint in the 330-patient Phase III...